Follow-up monitoring occurs through virtual visits, ensuring dose adjustments and side effect management remain accessible throughout the treatment journey
Springer-Verlag, 397-408, 1990
Furthermore, studies have shown that GLP-1 agonists reduce liver-associated mortality in T2DM patients [87]
Food and Drug Administration (FDA) has recognized the potential of GLP-1 agonists for weight loss by approving medications like semaglutide and liraglutide (Saxenda) specifically for this purpose
Because liraglutide leaves the body faster, side effects can subside quicker if you stop taking it
Yang JY, Lee SJ, Park HW, Cha YS (2006) Effect of genistein with carnitine administration on lipid parameters and obesity in c57bl/6j mice fed a high-fat diet